跳至主要内容
临床试验/NCT00452270
NCT00452270已完成3 期

A Double-Blind, Randomized, Parallel Group, Placebo Controlled Study, Evaluating the Decongestant Effect, Time to Onset, Duration of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold

Novartis1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2007年3月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Novartis
入组人数
60
试验地点
1
主要终点
To evaluate the decongestant effect of xylometazoline in subjects with

研究概览

简要总结

The aim of this study is to characterize the time profile of the decongestant properties of xylometazoline and to investigate its effect on sleep, general well-being and smell/taste.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Over 18 years
  • •Have had moderate common cold symptoms for less than 36 hours.

排除标准

  • •Congested/runny nose for more than two continuous weeks in the previous 12 months
  • •Deviated septum or nasal polyps
  • •Recent use of antibiotics
  • •Recent sinusitis
  • •Other protocol-defined inclusion/exclusion criteria may apply.

结局指标

主要结局

To evaluate the decongestant effect of xylometazoline in subjects with

common cold compared to placebo treatment by means of rhinomanometry over a period of 12 hours.

次要结局

  • To measure the peak subjective effect, time to onset of subjective relief of nasal obstruction
  • and duration of relief of nasal obstruction

研究者

发起方
Novartis
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验